EPLIN-α Expression in Human Oesophageal Cancer and Its Impact on Cellular Aggressiveness and Clinical Outcome.

Yinan Liu,Andrew J. Sanders,Lijian Zhang,Wen G. Jiang

2012-01-01

Abstract:Background: Epithelial protein lost in neoplasm-alpha (EPLIN-alpha) is a cytoskeletal protein whose expression is often lost or is aberrant in cancerous cells and tissues and whose loss is believed to be involved in aggressive phenotype. Our current study examined this molecule in human oesophageal tissues and investigated the cellular impact of EPLIN-alpha on oesophageal cancer cells. Materials and Methods: Expression of the EPLIN-alpha transcript in human oesophageal tissues (tumour, paratumour and normal) was determined using the Quantitative Polymerase Chain Reaction (Q-PCR) method. In vitro models, including invasion, cellular migration (Electrical Cell substrate Impedance Sensing based method), cell growth and matrix adhesion assays were employed in order to assess the biological influence of EPLIN-alpha expression on KYSE150 oesophageal cancer cells. Results: EPLIN-a expression was lower in tumour tissues compared to normal tissue. Grade 3-5 tumours had slightly lower levels of EPLIN-alpha compared with those of grade 2. Patients who died of oesophageal cancer had significantly lower levels of EPLIN-a compared to those who remained disease-free (p=0.022). Lower levels of EPLIN-alpha transcript were seen in advanced oesophageal cancer, including TNM stages 2 to 4. Reduced EPLIN-alpha expression was associated with lymphatic metastasis and local advanced T-stage cancel; including T2-T4. Forced expression of EPLIN-alpha in oesophageal cancer cells rendered cells less invasive and reduced their cell growth rate in vitro. Conclusion: Our study suggests that EPLIN-alpha is expressed at lower levels in oesophageal cancer tissues. This down-regulation has a prognostic value. Together with the findings that EPLIN-alpha inhibits cellular growth and invasion, we conclude that EPLIN-alpha is a tumour suppressor of oesophageal cancer.